Autopsy report · NCT03051451
Fixed Dose Combination of Fluoxetin and Metformin in the Management of Overweight and Obesity
Cause of deathFunding or business
“Business decision”
Life of this trial
- Suspended: paused, and may or may not restart.
- 150 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Phase 2
- Sponsor
- Laboratorios Silanes S.A. de C.V.
- Sponsor type
- Industry
- Conditions
- Overweight and Obesity
- Interventions
- combination metformin hydrochloride/ fluoxetine 500/20 mg; combination metformin hydrochloride/ fluoxetine 1000/20mg; Placebo Oral Tablet
- Participants
- 150 (planned, not actual)
- Sites
- 1
- Countries
- Mexico
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.